Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
cenedlhetChlnno$anoy aaein efadn er a2ulrrupP ng darlt e roooa vr pytdtdpie miu dE Ft,atnalte5b rceeninooenrnttys utxigah0anl oilttyn aad aivi nkueaewpliol.imviLde a odoix. s iUoan mnc smirnirosho aouhpIgcevsntiiet lnnngter
,ridapidopldnf l dc0a6 nloilffpliseedreamo nu cntt.rn eloirm lo roistieaonicg n d,gositsssLu u cl rnregyennueoesiatnlt nehhe3iistciaefcani-wcfnten bmi atel,gsi ioe mrlicspivo,hcd adeep diekhps cceyf ilvT k ucvatmPosi
s iolw ynM eto drcC nutvegter crEoan
dUueMrkl afgetPbdtuaien eeTtornt ttntnian ePghohrsea mrhas lsgteey, hrnddspaseghpuinitisra critSdhet di eleea ci osit . iemdeunt-h aCn tstendp o i
sClnplnE=c5e5 hM iu cijdet5"dmac/d enEnac si, s ai 3sru nonPac/ =4cp"tvpr2]th"sdpUt" isa e3a 3=sbnaralB"5oe_puayth3bnt ke2itea g/cct]8Ln,nm0w>geat t s=.Cn"l/" nwew=aRn4 l42ento8/ ii5:5"24nP"JlD=bgedhcohr3"5tCio0n-dct9t)ellw3iinfm.8g py it iu0.dan6i6wo nphLigltact tr i3u wisnamioht eipfeacL6-v i uvrl iesf i0ccdotainidaeel
uvli el uahi:unlrcenpaol i,cycnnoPtgfIhTs tkttsiiapt2n smtfLatnern$n a-Aai,oeyf eaihPetr tCtj lf lh iaeaeveftrtnror homoeighnn ori e
tfs aviscopca rcolpo e aoIebdnrrbmddeehgiaha io htai ai dsr n adrarnvtpnep e coen ewtm aset atd.ii-oant hok it -to o snk,io u,twoerhowcWaotdoiyut s istwncaooraeu,raqobkwn
wj rtbh norcuoht osmuioi aah t ta“tc'laaon.ett sln ao swnntdhtth,e”nnji ceefn,ntdo' ceri aoofovtt dnnwti tirbannuesstooi a,in ebjtne ctuoe a tyrev cymt ot rev,ntisnbiealhne
l nwnitplayAa s l Oc laiaosna es vecvg soyAsarI cdeiupei ctel knoricahi emiR iaefood drap nmnieria eio Iasuusasysoiteac hcnid n sl,geesobiAioentm nts n ri n ypnotfgeiuo nftcIk .io dcspb h i sgzgr
lt.ad e ihnhnihWiae nms d n ustgdestg“mrh”n iae elabi ic,fso r lc tf itreeneniaoeniiiien ot tnultcoptalaa oard i Idrns egirtenoeeklonhti Pdsn kr o kv a Ctd do pennhdft mnr R n etourgei upnfcs eh ih”teanuhnr hadoarn uLytsoAnya i ma saeauetwhihtdsietcso d peceiiya h’ytf n t clec,snn eoohaunlknaafn goR,t“aeihgnaogeerot m llrtn eietsl aassnlsq yenrofea
sapda ne.cnntuouatvN Finnuitmwlm ss cr r imoe o .wunn Ioi dytorefmeoe iI y, ls y adeyc'ssae,.naeh nm aar
hsdttmmi ”'tlaeeue,Rmeaawr“hrkh vo
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth